A Safety and PK Study of IV Eravacycline

Clinical trial NCT03696550 · COMPLETED

Trial details

NCT number: NCT03696550
Sponsor: Tetraphase Pharmaceuticals, Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bacterial Infections

Start date: 2018-12-20
Primary completion: 2021-03-14
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.